Australia markets closed

Zelira Therapeutics Limited (ZLD.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
1.0000+0.0300 (+3.09%)
At close: 03:51PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 9.29M
Enterprise value 2.21M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.16
Price/book (mrq)0.23
Enterprise value/revenue 2.07
Enterprise value/EBITDA -0.22

Trading information

Stock price history

Beta (5Y monthly) 1.12
52-week change 3-88.34%
S&P500 52-week change 3-13.03%
52-week high 38.9254
52-week low 30.9000
50-day moving average 31.3874
200-day moving average 34.3449

Share statistics

Avg vol (3-month) 311.26k
Avg vol (10-day) 325.36k
Shares outstanding 59.58M
Implied shares outstanding 6N/A
Float 85.36M
% held by insiders 133.26%
% held by institutions 13.27%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:175
Last split date 314 Apr 2022

Financial highlights

Fiscal year

Fiscal year ends 30 June 2021
Most-recent quarter (mrq)31 Dec 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-752.17%

Management effectiveness

Return on assets (ttm)-14.44%
Return on equity (ttm)-25.71%

Income statement

Revenue (ttm)1.3M
Revenue per share (ttm)0.19
Quarterly revenue growth (yoy)704.10%
Gross profit (ttm)435.09k
EBITDA -9.39M
Net income avi to common (ttm)-10.22M
Diluted EPS (ttm)-1.5050
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.61M
Total cash per share (mrq)1.04
Total debt (mrq)533.76k
Total debt/equity (mrq)1.32
Current ratio (mrq)9.60
Book value per share (mrq)5.44

Cash flow statement

Operating cash flow (ttm)-8.6M
Levered free cash flow (ttm)-4.64M